131 related articles for article (PubMed ID: 35150389)
1. The Antitumor Activity of hAMSCs Secretome in HT-29 Colon Cancer Cells Through Downregulation of EGFR/c-Src/IRTKS Expression and p38/ERK1/2 Phosphorylation.
Ebadi Zavieh S; Safari F
Cell Biochem Biophys; 2022 Jun; 80(2):395-402. PubMed ID: 35150389
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of Pinkbar/pAKT and MMP2/MMP9 Expression in MDA-MB-231 Breast Cancer Cells as Potential Targets in Cancer Therapy by hAMSCs Secretome.
Shakery T; Safari F
Cells Tissues Organs; 2023; 212(2):155-163. PubMed ID: 34695828
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of SgK269 expression in colon cancer patients and the effects of hAMSCs secretome on tumor invasion through SgK269/c-Src/p-P130Cas/p-Paxillin/p-ERK1/2 signaling pathway in HT-29 colon cancer cells.
Safari F; Ansari Dogaheh F; Dadashi H
3 Biotech; 2023 Nov; 13(11):346. PubMed ID: 37744286
[TBL] [Abstract][Full Text] [Related]
4. Potential therapeutic effects of hAMSCs secretome on Panc1 pancreatic cancer cells through downregulation of SgK269, E-cadherin, vimentin, and snail expression.
Alidoust Saharkhiz Lahiji M; Safari F
Biologicals; 2022 Apr; 76():24-30. PubMed ID: 35216916
[TBL] [Abstract][Full Text] [Related]
5. The inhibition of Panc1 cancer cells invasion by hAMSCs secretome through suppression of tyrosine phosphorylation of SGK223 (at Y411 site), c-Src (at Y416, Y530 sites), AKT activity, and JAK1/Stat3 signaling.
Safari F; Shafiee Nejad N; Aghaei Nejad A
Med Oncol; 2022 Jan; 39(3):28. PubMed ID: 35059869
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the in vitro therapeutic effects of human amniotic mesenchymal stromal cells on MiaPaca2 pancreatic cancer cells using 2D and 3D cell culture model.
Rahmani Z; Safari F
Tissue Cell; 2021 Feb; 68():101479. PubMed ID: 33383360
[TBL] [Abstract][Full Text] [Related]
7. The SH3 domain distinguishes the role of I-BAR proteins IRTKS and MIM in chemotactic response to serum.
Li L; Liu H; Baxter SS; Gu N; Ji M; Zhan X
Biochem Biophys Res Commun; 2016 Oct; 479(4):787-792. PubMed ID: 27693783
[TBL] [Abstract][Full Text] [Related]
8. The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling.
Asbagh LA; Vazquez I; Vecchione L; Budinska E; De Vriendt V; Baietti MF; Steklov M; Jacobs B; Hoe N; Singh S; Imjeti NS; Zimmermann P; Sablina A; Tejpar S
Oncotarget; 2014 Oct; 5(20):10070-83. PubMed ID: 25301722
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation.
Mugabe BE; Yaghini FA; Song CY; Buharalioglu CK; Waters CM; Malik KU
J Pharmacol Exp Ther; 2010 Jan; 332(1):116-24. PubMed ID: 19797620
[TBL] [Abstract][Full Text] [Related]
10. Ultraviolet irradiation can induce evasion of colon cancer cells from stimulation of epidermal growth factor.
Adachi S; Yasuda I; Nakashima M; Yamauchi T; Kawaguchi J; Shimizu M; Itani M; Nakamura M; Nishii Y; Yoshioka T; Hirose Y; Okano Y; Moriwaki H; Kozawa O
J Biol Chem; 2011 Jul; 286(29):26178-87. PubMed ID: 21646361
[TBL] [Abstract][Full Text] [Related]
11. Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells.
Said AH; Hu S; Abutaleb A; Watkins T; Cheng K; Chahdi A; Kuppusamy P; Saxena N; Xie G; Raufman JP
Biochem J; 2017 Feb; 474(5):647-665. PubMed ID: 28008134
[TBL] [Abstract][Full Text] [Related]
12. Combined EGFR and c-Src antisense oligodeoxynucleotides encapsulated with PAMAM Denderimers inhibit HT-29 colon cancer cell proliferation.
Nourazarian AR; Najar AG; Farajnia S; Khosroushahi AY; Pashaei-Asl R; Omidi Y
Asian Pac J Cancer Prev; 2012; 13(9):4751-6. PubMed ID: 23167414
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor acts as a negative regulator for bacterium nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via an Src-dependent p38 mitogen-activated protein kinase signaling pathway.
Mikami F; Gu H; Jono H; Andalibi A; Kai H; Li JD
J Biol Chem; 2005 Oct; 280(43):36185-94. PubMed ID: 16115866
[TBL] [Abstract][Full Text] [Related]
14. Alpha 2-Adrenergic Receptor Agonist Brimonidine Stimulates ERK1/2 and AKT Signaling via Transactivation of EGF Receptors in the Human MIO-M1 Müller Cell Line.
Harun-Or-Rashid M; Hallböök F
Curr Eye Res; 2019 Jan; 44(1):34-45. PubMed ID: 30198788
[TBL] [Abstract][Full Text] [Related]
15. Ursolic acid inhibits proliferation and induces apoptosis of HT-29 colon cancer cells by inhibiting the EGFR/MAPK pathway.
Shan JZ; Xuan YY; Zheng S; Dong Q; Zhang SZ
J Zhejiang Univ Sci B; 2009 Sep; 10(9):668-74. PubMed ID: 19735099
[TBL] [Abstract][Full Text] [Related]
16. Insulin receptor tyrosine kinase substrate activates EGFR/ERK signalling pathway and promotes cell proliferation of hepatocellular carcinoma.
Wang YP; Huang LY; Sun WM; Zhang ZZ; Fang JZ; Wei BF; Wu BH; Han ZG
Cancer Lett; 2013 Aug; 337(1):96-106. PubMed ID: 23693078
[TBL] [Abstract][Full Text] [Related]
17. Src-mediated aryl hydrocarbon and epidermal growth factor receptor cross talk stimulates colon cancer cell proliferation.
Xie G; Peng Z; Raufman JP
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G1006-15. PubMed ID: 22361730
[TBL] [Abstract][Full Text] [Related]
18. Src-dependent EGFR transactivation regulates lung inflammation via downstream signaling involving ERK1/2, PI3Kδ/Akt and NFκB induction in a murine asthma model.
El-Hashim AZ; Khajah MA; Renno WM; Babyson RS; Uddin M; Benter IF; Ezeamuzie C; Akhtar S
Sci Rep; 2017 Aug; 7(1):9919. PubMed ID: 28855674
[TBL] [Abstract][Full Text] [Related]
19. Src-mediated cross-talk between farnesoid X and epidermal growth factor receptors inhibits human intestinal cell proliferation and tumorigenesis.
Peng Z; Raufman JP; Xie G
PLoS One; 2012; 7(10):e48461. PubMed ID: 23119029
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.
Das R; Mahabeleshwar GH; Kundu GC
J Biol Chem; 2004 Mar; 279(12):11051-64. PubMed ID: 14704150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
